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INTRODUCTION
Epilepsy is one of the most common serious neuro-
logical problems and is occurred because of sudden,
severe and intermittent disturbance of the nervous sys-
tem due to abnormal electrical activity of neurons(1).
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Abstract-
Background: Epilepsy is considered to be among the most prevalent neurological disorders and one of most
important health issues. It costs huge expenses for health system, and influences the individual and
social quality of life of the patients. Despite its importance, the studies conducted in Iran to determine
the prevalence of epilepsy are limited. The present study evaluated the Prevalence of active epilepsy in
Kerman. 
Methods: The present cross sectional study was carried out on 2919 individuals from different neighbor-
hoods of Kerman in two stages, first stage was screening process by trained questioners, and the second
one was the confirmation of definite diagnosis. Cases of Inactive epilepsy were eliminated from the
study. Questionnaires containing demographic information and paraclinical analyses were filled out for
each individual. Also 628 epileptic patients in Kerman, who had referred to a referral center, were ana-
lyzed concerning epilepsy subtypes. 
Results: From 126 suspicious individuals, 23subjects were diagnosed to be epileptic. Point prevalence of
active epilepsy was 7.87/1000 individuals. It was equal in both sexes, with a significant increase in
individuals having low education (P= 0.029). The generalized epilepsy had a higher frequency. Of the
patients, 56.6% suffered from psychiatric diseases. Electroencephalography (EEG) in 13 patients
(56.5%) showed epileptic waves. Family history of seizure was positive in 17.3% of the patients. 
Conclusion: Point prevalence of active epilepsy is 7.87/1000 in Kerman, as same as developing countries.
The prevalence was significantly higher in individuals with lower education.
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Seizures are broadly classified into generalized, partial,
and unclassifiable types(2). Partial seizures are also more
classified into simple and complex forms according to
the ability to disturbing consciousness(2). Epilepsy is
often accompanied with the decrement in the level of the
consciousness, or abnormal motor, sensory or autonomic
manifestations. Epilepsy influences the quality of per-
sonal and social life in the affected individuals. A part of
this influence is caused by the physical effects of the
seizures (such as physical injuries) or the frequency of
seizures, and another part is the result of long-term use
of medicines(3). Depression, anxiety, employment restric-
tion, and in uncommon circumstances death, are among
the other adverse effects of seizures(4,5,6). There  are multi-
ple causes for the epileptic attacks, and among these we
can point to: head trauma, cerebral infections, tumors
and cerebral infarctions. However at least in some
patients the seizures are idiopathic (7). Nowadays, numer-
ous numbers of epidemiological studies are being carried
out regarding the issue under discussion worldwide.
Among the main objectives of these studies is to deter-
mine the prevalence of epilepsy in each and every
region, which, equipped with accurate information,
researchers are enabled to provide an appropriate infra-
structure of diagnosis-treatment facilities. Since the fac-
tors which pave the way for exposure to epileptic
seizures and their frequency are different in different
societies (trauma for instance), another objective of epi-
demiological analyses concerning epilepsy is to help
decrease the cases of epilepsy through regional epidemi-
ological analyses, and recognition, elimination, or reduc-
tion of these risk factors(8,9). Studies showed that in
African countries the prevalence of epilepsy was
between 0.2% to 5.8% (10). Another studies showed that
the least prevalence was in Ethiopia (0.5%) and the most
was in Ivory Coast (5.8%)(11). Also studies in Europe
showed the prevalence of 0.4% to 0.8% (12). In one study
in USA that information was collected from the 19 states
the prevalence of 0.84% for this disease was observed
(13)
. In Asia various studies was done for this purpose. For
example in different door-to-door studies, prevalence of
active epilepsy was reported in India to be 0.39% and
0.77% in Laos. Whereas it was 1% and 1.07% in
Pakistan and Vietnam respectively (8). There are very lim-
ited published studies for the prevalence of epilepsy in
Iran. Mohammadi et al in 2005 reported for the preva-
lence of 1.8% for epilepsy while studying the epidemiol-
ogy of psychiatric disorders in Iran (14). In Khadivi et al
article the prevalence of 0.22% was reported in
Chaharmah and Bakhtyari province of Iran (15).
Unfortunately despite of epidemiologic importance of
this subject, there is not accurate prevalence rate of
epilepsy in Kerman province and other parts of Iran.
Whilst with paying attention to the importance of this
disease and preparing the health facilities for the treat-
ment of this patients and community education, this mat-
ter appears more indispensable. According to the items
stated above, the main goal of this study was the deter-
mination of prevalence of epilepsy in Kerman city.
While also the abundance of different seizure subtypes
were evaluated among 628 epileptic patients who came
to a referral center in Kerman.
MATERIALS AND METHODS
In this population based cross-sectional study in
Kerman city, ten different districts was selected random-
ly. A number of three major clusters were selected in
each neighborhood (region), of which approximately 30
to 35 families were questioned referring to the clusters
consecutively. All the members in every family went
through screening.
Research team: Including 2 neurologists (organizers
as well), 3 trained questioners, and an expert for upload-
ing the information for analysis.
Screening tool: we adopted a questionnaire that was
first used in an Ecuadorian study. That study was
designed for evaluation of the prevalence of epilepsy by
Placencia et al (16,17).
This questionnaire was used in other studies in
Brazil and Zambia (18,19). The questionnaire was translated
into Persian and we added more questions related to
demographic characteristics.
We tested it before the beginning of the study in 40
subjects (20 with epilepsy and 20, without).
The performance of this pretest was sensibility 95%
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and specificity 72%. This questionnaire consisted of nine
questions, both questions one and two must be affirma-
tive to renders the subject positive and any question
from three to nine renders the subject positive if it was
affirmative .The questionnaire was designed to identify
all cases who suffered all types of epileptic seizures. The
adults (subjects of 13 or older) were questioned directly,
otherwise, a family member with comprehensive knowl-
edge of the other members was asked to fill out the ques-
tionnaire according to the questionerŅs instructions. In
the case of children we asked their parents to fill the
questionnaire. In our study active epilepsy was defined
according to the ILEA definition which included the
patients who had seizure attack in the last 5 years, or
were taking antiepileptic drugs (AEDs) at the time of
study (20).
Study Design
The present study was conducted in two stages. The
first stage took from late November 2010 to late May
2011, in which three trained questioners screened all the
members of every family using standard screening ques-
tionnaires. Second stage: those subjects considered to be
positive, eventually underwent examination for further
analysis, including EEG and cerebral imaging (if neces-
sary) by 2 neurologists for definite epilepsy diagnosis.
Examination by neurologist: those considered posi-
tive in the screening were interviewed by 2 neurologists,
conducted either on the phone or personal. In suspected
cases we also interviewed relatives or witnesses of the
attacks .Neurologists used the standard criteria in the
ILEA for epilepsy. EEG was done in difficult cases or in
subjects who EEG had not been done .EEGs with spike
or sharp waves were considered epileptic and instances
with non-epileptic EEG changes (e.g. slowing) where
grouped as abnormal (nonspecific EEG changes). Brain
imaging (CT/MRI) was done when it was necessary or it
was searched in the patient’s medical records.
Information about taking or not taking the AEDs and
family history of epilepsy in first degree relatives was
also collected (first group).
For better evaluation of the redundancy rate of dif-
ferent seizure subtypes, we studied 628 epileptic patients
who were referred to a referral center in Kerman city.
These subjects were all lived in Kerman at the time of
the study) second group)
STATA 11 software was employed for analysis of
data according to the age, sex, and education. The main
variables were initially described in general, and after
that we compare the groups with chi-square test. 
RESULTS
A total of 2919 individuals (1426 male1493 and
female) went through screening in our survey. Of the
2919 screened individual, 239 individuals were consid-
ered suspicious, of which 101 individuals were eliminat-
ed after phone interviews by neurologists due to lack of
seizure-based history. The remaining 138 subjects were
invited for personal interviews and the required exami-
nations, of which 12 subjects withdrew from the study.
From the remaining 126 subjects (who experienced
epileptic seizure at least once in their lives), 23 subjects
were definitely diagnosed with active epilepsy subse-
quent to complementary questions, examining of the
patients’ medical records, and EEG (if necessary). The
patients were comprised of 12 men (52.1%) and 11
women (47.8%). Table 1 shows the age- and gender-spe-
cific prevalence rates of adult patients with active epilep-
sy in this study. Generalized tonic clonic epilepsy was
seen in 56.5% of patients and 39.1% had focal epilepsy.
(First group in table 2) No significant difference was
observed between the two sexes (P>0.05). Epileptic
patients had lower education compared to non-epileptic
individuals and the difference between the two groups of
healthy and patient was meaningful (P = 0.029).
A number of 13 patients (56.6%) had history of neu-
ropsychiatric disorders with depression being the most
prevalent case (21.7%). Records from 18 patients (78.
2%) showed treatments with antiepileptic drugs, while 5
patients (21.7%) did not mention any history of medi-
cine use. EGG showed epileptic discharges in 56.5% of
the cases, 30.4% portrayed non-specific changes, and for
13% of the patients EGG was absolutely normal.
Imaging results of CT/MRI was normal for 11(73.3%) of
the cases, while 4(26.6%) cases showed abnormal
results. The remaining 8 patients did not undergo imag-
ing for disparate reasons. Familial epileptic history was
positive in 17.3% of the cases.
As observable, table 3 shows the comprehensive
results of the analyses on epileptic patients concerning
medicine use, familial history, imaging findings, EEG,
and incidence of psycho-neurological diseases.
Furthermore, the medical records pertaining to 628
patients of a referral center in Kerman were also investi-
gated in an attempt to determine more accurately the dif-
54
Acta Neurologica Taiwanica Vol 21 No 2 June 2012
Table 1. The prevalence rate (per 1000) of patients with active epilepsy in Kerman, Iran 
Age(year) Kerman population Number of active epilepsy (prevalence ‰)(95% CI)in Kerman
Men Women Both sex Men Women Both sex
Under 9 119 101 220 3 (25.2)(17.66-27.74) 3 (29.7)(24.4-35.0) 6(27.3)(23.1-31.6)
10-19 169 179 348 2(11.8)(9.7-13.9) 1 (5.6)(4.4-6.8) 3(8.6)(4.44-12.76)
20-29 345 385 730 0 4 (10.4)(6.6-14.1) 4 (5.5)(1.1-9.6)
30-39 276 298 574 2(7.2)(5.1-9.3) 0 2(3.5)(2.0-5.0)
40-49 138 138 276 2 (14.5)(12.4-16.6) 2(14.5)(12.4-16.6) 4 (14.5)(12.4-16.6)
50-59 168 183 351 1(5.9)(5.5-6.3) 0 1(2.8)(2.4-3.4)
60-69 150 131 281 1(6.7)(6.1-7.3) 0 1(3.5)(2.1-5.9)
Upper 70 63 78 141 1(15.9)(10.7-21.1) 1(12.8)(7.6-17.9) 2(14.2)(8.8-19.7)
Total 1426 1493 2919 12(8.4)(4.6-12.2) 11(7.4)(3.6-11.2) 23(7.9)(4.5-11.3)
Table 2. Frequency of different types of epilepsy among our
patients
Seizure type First group Second group 
generalized 56.5% 51.1%
focal 39.1% 44.1%
unclassifiable 4.3% 4.8%
First group: Patients from our house-to-house survey 
Second group: Patients from the referral center
Graph1:  Distirbtion of age of epilepsy onset
ferent subtypes of seizure for patients in Kerman (Table
4). All the mentioned patients were residents of Kerman
within the time period of the study. Of these, 321
patients (51.1%) suffered from generalized seizures and
277 (44.1%), from focal seizures. (Second group in table
2)The highest rate of epilepsy affliction was dedicated to
the first year of life. The foregone rate gradually declines
up to adolescence and portrays a much smaller peak in
the 7th decade of life (Graph 1). The number of male
patients was, again, more in this group; the difference,
however, was not significant. Also the causes of epilepsy
were studied in this group of patients, and the results are
shown in table 5. 
DISCUSSION
Almost 65 million individuals are suffering from
epilepsy worldwide (21). Population-based epidemiologi-
cal studies on epilepsy are considered to be significantly
important, since their results are broadly influential in
determining preventive policies and providing medical
and diagnostic measures. Following similar objectives,
the present population-based study investigated the
prevalence of epilepsy and a number of its governing
factors in Kerman. The conducted investigations showed
that the point prevalence of active epilepsy in Kerman is
7.8/1000 individuals. Studies across the world have
reported different statistics. The incidence rate of epilep-
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Table 3. Characteristic data in epileptic patients.
Frequency %
History of Neuropsychiatric disorders No 10 43.3
Yes 13 56.5
Type of Neuropsychiatric disorders Depression 5 21.7
Anxiety 4 17.3
Mental
Retardation 2 8
Hyperactivity 1 4
Migraine 1 4
History of AEDs consumption Yes 18 78.2
No 5 21.7
Causes of not using AEDs Limited knowledge regarding the disease 3 60
Lack of faith in treatment 1 20
Low of financial ability 1 20
EEG Normal 3 13
Non-Specific changes 7 30.4
Epileptic 13 56.5
CT/ MRI Normal 11 73.3
Abnormal
Cortical atrophy 2 13.3
Old Stroke 1 6.6
Mesial Temporal Sclerosis 1 6.6
Total 4 26.6
Family History Positive 4 17.3
Negative 19 82.6
sy is reported 2.6 to 3.8 individuals per one thousand in
Argentina (22,23), 1.5 to 4.5 in China (24,25), 3.8 in India (8), and
0.8 to 8.5 in Turkey (26,27). Studies in Arab countries show
various results from 0.9 individuals per one thousand in
Sudan to 6.5/1000 in Saudi Arabia (28). A study by
Mohammadi et al. reported prevalence of epilepsy in
Iran to be 18/1000(14). It seems that prevalence of epilep-
sy in developing countries is twice compared to that of
developed countries (29); the statistics in these countries,
however, are different as well. As indicated by different
studies, incidence of epilepsy in European countries is
close to each other and ranges from 0.4% to 0.8% (12). A
study of epilepsy in the US, investigating subjects from
19 states, showed the incidence of 0.84% (13).
56
Acta Neurologica Taiwanica Vol 21 No 2 June 2012
Table 4. Frequency of epilepsy subtypes in epileptic patients
SEX
Women Men
Frequency % Frequency %
Primary generalized tonic clonic 125 41.3 120 36.8
Secondary generalized tonic clonic 59 19.5 108 33.1
Atypical  petitmal 5 1.6 10 3
Complex Partial Seizure 22 7.2 24 7.3
Focal Seizure 6 2 4 1.2
JME 29 9.6 10 3
(Juvenile myoclonic epilepsy)
Lennox-Gastaut Syndrome 5 1.7 3 0.9
Petitmal (Typical) 1 0.3 2 0.6
Simple partial Seizure 5 1.7 1 0.3
Atonic 4 1.3 5 1.53
Tonic 11 3.6 4 1.2
West Syndrome 2 0.7 0 0
Focal Seizure with secondary Generalization 15 5 18 5.5
Complex Febrile Seizure 13 4.3 17 5.2
Total 302 100 326 100
Se
iz
ur
e 
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bt
yp
es
Table 5. Age-specific etiologies of active epilepsy in Kerman, Iran
Age Cerebral Palsy Vascular Head injury Tumors Others Total
First  year 28 0 0 0 10 38
2 ė 10 21 2 1 1 9 34
11 ė 20 9 1 6 1 5 22
21 ė 30 1 0 12 4 4 21
31 ė 40 0 3 8 1 3 15
41 ė 50 0 6 3 0 0 9
51 ė 60 0 6 2 2 1 11
61 ė 70 0 9 0 1 0 10
> 70 0 7 0 2 0 9
Total 59(34.9%) 34(20.1%) 32(18.9%) 12(7.1%) 32(18.9%) 169(100%)
Others included: Febrile convulsions, CNS Infections, Metabolic Disorders, Drug abuse and Multiple Sclerosis
Thurman et al stated that since different studies have
employed various media for sampling, the results cannot
be compared properly; thus there is a need to standardize
the epidemiological studies on epilepsy(21). The foregone
different media include total population, population of
schools, hospital referrers, or even special needs
schools(30). The manner of diagnosis of epilepsy is
undoubtedly influential in these studies as well, and
affects the results based on whether the patient him/her-
self has reported or is examined by a physician(29). The
present study attempted to heighten the accuracy by the
measures explained in the methodology (house to house
investigation as well as approval of diagnosis by special-
ists).
In our study the results showed no meaningful dif-
ference between sexes. However different studies
revealed various results. Studies conducted in England
(31)
, Singapore, Italy, India, and Sweden, similar to the
present study, reported no sex domination i.e. the differ-
ence between male and female was small, while in
Taiwan, China, Turkey, Finland, and Estonia, men had
dominance and in Pakistan and Nepal women were dom-
inant (8,12,32).
Concerning changes in the EEG, 13 % of the cases
were normal, while the rest showed epileptic or non-spe-
cific changes. In an epidemiological study in India,
Panagariya et al. observed that 15 % of the subjects
maintained normal EGGs which were almost similar to
our results (33). In another study in Japan, however, 59.5
% of the cases showed epileptic discharges (34).
Concerning imaging, 26.6% of the patients of this
study showed abnormal findings while in the study of
Panagariya et al., imaging changes were observed in
66.5 % of the cases (33). And in Japan 27.4 % of the cases
had changes in CT/MRI (34). The method of imaging
(MRI or CT) is effective in the resulting statistics how-
ever. 
The results of this study indicated a significant dif-
ference between epilepsy prevalence and the level of
education i.e. the incidence of epilepsy was higher in
individuals with lower education, that can be attributed
to the presence of cerebral palsy or head injury among
these patients which can lead to many problems in their
education, This finding conforms to studies carried out
in the US (13), Vietnam (35), and Turkey(36) . But Ferro
observed no such relationship in England(31). In a study in
Taiwan, Chen et al. had found that the presence of
epilepsy was not significantly affected by socioeconomic
status(37).
Positive familial history of epilepsy in blood rela-
tives of the patients was 17.3% in this study which was
close to some studies. For example in Turkey, positive
familial history was seen in 14.3% of patients (36). Also in
another study in Tanzania, A family history of epilepsy
in first-degree relatives was found in 46.6% of
patients(38). Etiology of this various findings isn’t clear
,maybe it is an incidental finding, or maybe it is related
to other factors which must be investigated further .
Rate of the patients using antiepileptic medicine was
78 % in this study. The same rate was 83.9% for adults
in a study in the US (13) and 89% in a study in Turkey(36).
About 60 % of these individuals stated that unfamiliarity
with the symptoms of the disease and not visiting physi-
cians as the reasons for not taking medicine which high-
lights the necessity for more planning and education
regarding the importance of epilepsy and its symptoms.
According to previous studies the most common
psychiatric disorders in epileptic patient were depres-
sion, anxiety and psychosis (39-43). In the present study, in
general, 56.5% of the patients mentioned psycho-neuro-
logical disorders, with depression being the most
observed disorder with 21.7%. The combination of
depression and anxiety was observed in 39% of the
patients. In a study conducted in the US in 2007 howev-
er, the most prevalent psychologic disorder, anxiety, was
reported as 22.8% and the combination of depression
and anxiety as 34.2%(39).
In the conducted analyses on 628 referred epileptic
patients, notwithstanding the higher incidence in males,
no significant difference was observed concerning sex
which concurred the previous findings.
In this study, generalized seizure was the most com-
mon subtype, a few studies are consistent with this find-
ing (44), but in most of the previous studies, the complex
partial seizure was the most common seizure subtype(32).
The excess of generalized seizure in our findings is
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maybe partially due to high rates of trauma and drug
abuse (others in table 5) which can mostly lead to gener-
alized seizure, whilst in our country it is possible that the
complex partial seizures is underreported because of
stigma that exists in Asian countries to the psychiatric or
other unusual manifestations of complex partial seizures
(37)
.
The rate of male patients suffering from secondary
generalized epilepsy was 64.6 % which may be due to
occupational traumas or accidents to which men are
more exposed (P < 0.001). Another point to be men-
tioned is that JME (Juvenile myoclonic epilepsy) was
more observed in females (P = 0.006) which may be
caused by the replacement of childhood absence by JME
in older ages, being more common in girls. It may also
be due to genetic causes in Iranian population, since
another study in Iran (Isfahan) reported increased inci-
dence of JME in girls compared to boys (45). The foregone
issue calls for further research.
In our study 26.9% of epileptic patients had identifi-
able cause, which is slightly different from other studies
in Tanzania, 34% (46), Nigeria, 34.9% (47) and Taiwan
where in the study by Chen et al., 35.1% of the patients
had identifiable causes (32). This difference could be
caused by using different paraclinic methods in various
studies. 
The most common causes of epilepsy in children are
cerebral palsy (CP) and febrile convulsion (FC). High
rates of CP in Iran are due to   peripartum injury. Our
findings about FC are correlated with other studies in
Tanzania and Nigeria(46,47). In adults head injury is the
most common cause of epilepsy as with study in Taiwan
by Chen et al. in 2006(32). In old age vascular events is
the major cause of epilepsy which is consistent with pre-
vious findings (48) (Table 5).
In conclusion, our findings show that point preva-
lence of active epilepsy is 7.87/1000 in Kerman. This
prevalence is as same as developing countries and was
higher in patients with low education.
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